Who owns CENTURY THERAPEUTICS INC?
- Ticker: IPSC
- CUSIP Number: 15673t100
Tip: Access positions for across all investors
Analyze quarterly positions in Century Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Century Therapeutics stock
Who bought or sold CENTURY THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| VR Adviser | 3.4M | $14M | 100% | Mar 2024 |
|
| FMR | 3.4M | $14M | -25% | Mar 2024 |
|
| Casdin Capital | 3.2M | $13M | 0% | Mar 2024 |
|
| Boxer Capital | 1.8M | $7.3M | 100% | Mar 2024 |
|
| BlackRock | 1.5M | $6.3M | -6% | Mar 2024 |
|
| DAFNA Capital Management | 1.3M | $5.5M | 0% | Mar 2024 |
|
| Avidity Partners Management | 1.2M | $5.1M | -10% | Mar 2024 |
|
| Vanguard Group | 1.1M | $4.8M | 1% | Mar 2024 |
|
| Tang Capital Management | 900k | $3.8M | -16% | Mar 2024 |
|
| Baker Bros. Advisors | 798k | $3.3M | 0% | Mar 2024 |
|
| Federated Investors | 619k | $2.1M | 0% | Dec 2023 |
|
| Octagon Capital Advisors | 540k | $2.3M | 100% | Mar 2024 |
|
| Geode Capital Management | 511k | $2.1M | 10% | Mar 2024 |
|
| Millennium Management | 357k | $1.5M | 157% | Mar 2024 |
|
| Jacobs Levy Equity Management | 294k | $1.2M | 191% | Mar 2024 |
|
| Morgan Stanley | 214k | $897k | -34% | Mar 2024 |
|
| Northern Trust | 185k | $772k | -1% | Mar 2024 |
|
| Charles Schwab Investment Management | 152k | $636k | 2% | Mar 2024 |
|
| Bridgeway Capital Management | 118k | $492k | -29% | Mar 2024 |
|
| Schonfeld Strategic Advisors | 93k | $389k | 100% | Mar 2024 |
|
| Wealth Enhancement Advisory Services | 78k | $327k | 0% | Mar 2024 |
|
| Bank of New York Mellon | 71k | $296k | -22% | Mar 2024 |
|
| Citadel Advisors | 65k | $273k | -37% | Mar 2024 |
|
| Nuveen Asset Management | 60k | $251k | 2% | Mar 2024 |
|
| CornerCap Investment Counsel | 52k | $215k | 0% | Mar 2024 |
|
| Bank of America Corporation | 42k | $177k | -1% | Mar 2024 |
|
| Goldman Sachs Group | 39k | $164k | -12% | Mar 2024 |
|
| Rhumbline Advisers | 34k | $141k | 2% | Mar 2024 |
|
| Dimensional Fund Advisors | 31k | $130k | -4% | Mar 2024 |
|
| UBS Group | 29k | $120k | 12% | Mar 2024 |
|
| Parametrica Management | 28k | $116k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 26k | $107k | 69% | Mar 2024 |
|
| Cubist Systematic Strategies | 19k | $79k | 100% | Mar 2024 |
|
| Barclays | 17k | $69k | -49% | Mar 2024 |
|
| Virtu Financial | 14k | $47k | 100% | Dec 2023 |
|
| New York State Common Retirement Fund | 14k | $57k | 0% | Mar 2024 |
|
| Occudo Quantitative Strategies | 14k | $57k | 100% | Mar 2024 |
|
| Jane Street | 12k | $51k | -31% | Mar 2024 |
|
| American International | 12k | $39k | 0% | Dec 2023 |
|
| Alliancebernstein | 12k | $38k | -9% | Dec 2023 |
|
| Mirae Asset Global Investments | 11k | $39k | 100% | Mar 2024 |
|
| Abel Hall | 10k | $42k | 0% | Mar 2024 |
|
| Founders Financial Securities | 10k | $42k | 0% | Mar 2024 |
|
| Deutsche Bank Aktiengesellschaft | 9.7k | $41k | -66% | Mar 2024 |
|
| Wells Fargo & Company | 8.3k | $35k | 15% | Mar 2024 |
|
| Point72 | 6.4k | $27k | 100% | Mar 2024 |
|
| Citigroup | 4.6k | $19k | 31% | Mar 2024 |
|
| Tower Research Capital | 4.4k | $18k | -84% | Mar 2024 |
|
| Ohio Pers | 4.3k | $18k | 100% | Mar 2024 |
|
| Brian McDonald | 2.9k | $12k | -30% | Mar 2024 |
|
| Russell Investments | 2.9k | $12k | 0% | Mar 2024 |
|
| Simplex Trading | 2.4k | $10k | 723% | Mar 2024 |
|
| California State Teachers Retirement System | 2.4k | $9.8k | -54% | Mar 2024 |
|
| Legal & General Group | 2.1k | $8.8k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 1.5k | $6.3k | -80% | Mar 2024 |
|
| Summit Investment Advisors | 905.00 | $3.8k | 0% | Mar 2024 |
|
| Amalgamated Bank | 706.00 | $3.0k | -63% | Mar 2024 |
|
| Qube Research & Technologies | 334.00 | $1.4k | 100% | Mar 2024 |
|
| GAMMA Investing | 295.00 | $1.2k | 68% | Mar 2024 |
|
| NISA Investment Advisors | 111.00 | $464.002200 | 0% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 6.00 | $25.000200 | 100% | Mar 2024 |
|
| CWM | 2.00 | $0 | 100% | Mar 2024 |
|
Who sold out of Century Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| New York Life Investment Management | Dec 2023 | 100k | $332k |
| Squarepoint Ops | Dec 2023 | 56k | $185k |
| Acadian Asset Management | Sep 2023 | 47k | $92k |
| Ameriprise Financial | Sep 2023 | 18k | $37k |
| Hrt Financial | Dec 2023 | 18k | $58k |
| SG Americas Securities | Dec 2023 | 13k | $43k |
| Neuberger Berman Group | Dec 2023 | 10k | $33k |
| Gladius Capital Management | Sep 2023 | 9.8k | $20k |
| Covestor | Dec 2023 | 3.00 | $0 |